Sabal Trust CO increased its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 1.2% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 89,207 shares of the medical research company’s stock after purchasing an additional 1,075 shares […]